Name: ENDV Balance Sheet - Endonovo Therapeutics Assets & Debt | Ledgeburg
Creator: Ledgeburg
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Total Assets, Current Assets, Cash and Equivalents, Total Liabilities, Long-term Debt, Short-term Debt, Shareholders Equity, Working Capital, Book Value Per Share

JavaScript is disabled. Some features may not work properly. For the best experience, please enable JavaScript in your browser.

ENDV - Endonovo Therapeutics, Inc.

USD | OTC Markets | Healthcare

ENDV Balance Sheet - Endonovo Therapeutics Assets & Debt | Ledgeburg

(in millions of USD)	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016	FY2015	FY2014	FY2013	FY2012	FY2011	FY2010	FY2009
Cash And Short Term Investments
Cash And Equivalents	-	0.1	0.0	0.0	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Restricted Cash	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Short Term Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash And Short Term Investments	-	0.1	0.0	0.0	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Receivables
Accounts Receivable	-	0.0	0.0	0.0	0.0	-	-	-	-	-	-	0.0	0.0	-
Current Assets
Inventory	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Prepaid Expenses
Non-Current Assets
Property, Plant & Equipment Gross	-	-	0.1	0.1	0.1	0.1	0.1	0.1	0.1	-	0.1	0.0	0.0	-
Current Liabilities
Accounts Payable	0.9	0.7	0.7	0.6	0.2	0.1	-	-	-	-	-	0.0	0.0	-
Short Term Debt
Non-Current Liabilities
Long Term Debt	7.2	7.3	6.8	6.9	8.2	7.4	3.2	0.0	1.6	-	-	-	-	-
Operating Lease Liabilities Non-Current
Common Equity
Common Stock	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-
Additional Paid In Capital
Supplementary Data
Total Debt	7.2	7.3	6.8	6.9	8.2	7.4	3.2	0.0	1.6	-	-	-	-	-
Net debt

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

(in millions of USD)	Q3 FY 23	Q2 FY 23	Q1 FY 23	Q4 FY 22	Q3 FY 22	Q2 FY 22	Q1 FY 22	Q4 FY 21	Q3 FY 21	Q2 FY 21	Q1 FY 21	Q4 FY 20	Q3 FY 20	Q2 FY 20	Q1 FY 20	Q4 FY 19	Q3 FY 19	Q2 FY 19	Q1 FY 19	Q4 FY 18	Q3 FY 18	Q2 FY 18	Q1 FY 18	Q4 FY 17	Q3 FY 17	Q2 FY 17	Q1 FY 17	Q4 FY 16	Q3 FY 16	Q2 FY 16	Q1 FY 16	Q4 FY 15	Q3 FY 15	Q2 FY 15	Q1 FY 15	Q4 FY 14	Q3 FY 14	Q2 FY 14	Q1 FY 14	Q4 FY 13
Cash And Short Term Investments
Cash And Equivalents	0.0	0.0	0.0	0.0	0.0	-	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

Current Liabilities
Accounts Payable	-	-	-	-	0.9	0.8	0.7	0.7	0.8	0.7	0.7	0.7	0.8	0.6	0.6	0.6	0.3	0.3	0.2	0.2	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Short Term Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue Current	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Lease Liabilities Current	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Accrued Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.9
Other Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Current Liabilities	23.7	23.1	25.5	33.4	21.0	20.7	19.8	17.7	20.3	19.2	18.3	16.8	15.3	14.9	14.1

Non-Current Liabilities
Long Term Debt	7.1	7.1	6.9	-	7.3	7.4	7.4	-	6.8	6.7	6.8	-	6.2	6.2	6.1	-	7.5	7.5	7.5	-	8.4	7.5	7.3	-	3.6	3.3	2.8	-	1.9	2.3	0.0	-	0.0	0.0	0.0	-	-	-	-	-
Operating Lease Liabilities Non-Current	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue Non-Current	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Tax Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Pension Obligations	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Non-Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non-Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	23.8	23.2	25.6	33.5	21.1	20.8	19.9	17.8	20.4	19.3	18.5	17.0	15.5	15.1	14.2	23.8

Common Equity
Common Stock	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-	-	-	-
Additional Paid In Capital	43.6	43.6	43.5	42.9	42.4	42.2	40.8	40.7	40.6	40.3	40.0	39.0	38.5	38.1	37.5	32.4	30.6
Retained Earnings	(66.6)	(65.9)	(67.9)	(75.1)	(62.0)	(61.4)	(58.9)	(56.4)	(58.8)	(57.3)	(56.0)	(53.3)	(51.3)	(50.2)	(48.6)	(52.9)	(47.3)
Accumulated Other Comprehensive Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Treasury Stock	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Minority Interest	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Stockholders Equity	(23.0)	(22.4)	(24.4)	(32.2)	(19.6)	(19.2)	(18.0)	(15.8)	(18.2)	(17.0)	(16.0)	(14.4)	(12.8)	(12.2)	(11.1)	(20.5)
Total Equity	(23.0)	(22.4)	(24.4)	(32.2)	(19.6)	(19.2)	(18.0)	(15.8)	(18.2)	(17.0)	(16.0)	(14.4)	(12.8)	(12.2)	(11.1)	(20.5)	(16.6)	(16.2)

Supplementary Data
Total Debt	7.1	7.1	6.9	-	7.3	7.4	7.4	-	6.8	6.7	6.8	-	6.2	6.2	6.1	-	7.5	7.5	7.5	-	8.4	7.5	7.3	0.0	3.6	3.3	2.8	0.0	1.9	2.3	0.0	0.0	0.0	0.0	0.0	0.0	-	-	-	-
Net debt	7.1	7.0	6.9	-	7.2	-	7.3	-	6.8	6.7	6.8	-	6.2	6.2	6.1	-	7.4	7.0	7.4
Working Capital	(23.7)	(23.1)	(25.4)	(33.4)	(21.0)	(20.7)	(19.7)	(17.6)	(20.2)	(19.1)	(18.2)	(16.8)	(15.3)	(14.9)	(14.0)	(23.6)	(19.8)
Book Value	(23.0)	(22.4)	(24.4)	(32.2)	(19.6)	(19.2)	(18.0)	(15.8)	(18.2)	(17.0)	(16.0)	(14.4)	(12.8)	(12.2)	(11.1)	(20.5)	(16.6)	(16.2)
Tangible Book Value	(23.7)	(23.4)	(25.5)	(33.4)	(21.0)	(20.7)	(19.8)	(17.7)	(20.3)	(19.2)	(18.4)	(16.9)	(15.5)	(15.1)	(14.2)	(23.7)	(19.9)

Non-Current Assets
Property, Plant & Equipment Gross	-	-	-	-	-	-	-	-	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	-	-	-	-
Accumulated Depreciation	-	-	-	-	-	-	-	-	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1
Property,Plant & Equipment Net	-	-	-	-	-	-	-	-	-	-	-	0.0	0.0	0.0	0.0	0.0	0.0
Long Term Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Equity Method Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Goodwill	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Intangible Assets	0.8	0.9	1.1	1.3	1.4	1.6	1.8	1.9	2.1	2.2	2.4	2.6	2.7	2.9	3.0	3.2	3.4	3.5
Operating Lease Right Of Use Assets	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Tax Assets	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Non-Current Assets	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non-Current Assets	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	0.8	1.0	1.2	1.3	1.5	1.6	1.8	2.0	2.1	2.3	2.5	2.6	2.7	2.9	3.1	3.3	3.4